by Webdesign Squad | Mar 5, 2021 | News
Outstanding results from SCOPE 1 randomized, controlled, multicentric clinical trial, proving the efficacy of treating life-threatening Abdominal Aortic Aneurysm (AAA), by thrombogenic fibers embolization of the aneurysm sac when performing an EndoVascular Aneurysm...
by Webdesign Squad | Mar 5, 2021 | News
EUR 12 million financing comprising three tranches of EUR 4 million straight bonds. Clearing financial path to achieve major clinical milestones in view of regulatory approvals. Download press...
by Webdesign Squad | Mar 5, 2021 | News
• Positive results from the first clinical study on 3 patients implanted between May and September 2018 • The implant technique, via laparoscopy and open surgery, was validated, surgical safety was also verified • Implantable in about 20 minutes with minimally...
by Webdesign Squad | Mar 5, 2021 | News
Carvolix announces today the positive conclusion of its OPTIMISE first clinical study for KALIOS, its adjustable mitral repair device. KALIOS has been implanted in five patients between January and May of the current year by Prof. Martin Andreas, Principal...
by Webdesign Squad | Mar 5, 2021 | News
Carvolix hosted a Key Opinion Leader event Wednesday, May 23, 2018 on New Generation Technologies for Minimally Invasive Surgery of the Mitral Valve and Abdominal Aorta.Key opinion leaders (KOLs) present were Professor Christian Latrémouille (Georges Pompidou European...
Recent Comments